SAB Biotherapeutics, Inc.SABSNASDAQ
Loading
Revenue minus cost of goods sold
Percentile
P17
Within normal range
vs 5Y Ago
-0.1x
Contraction
Streak
1 yr
Consecutive growthContracting
| Period | Value | YoY Change |
|---|---|---|
| TTM | $-3.13M | +9.8% |
| 2024 | $-3.47M | -130.4% |
| 2023 | $-1.51M | -107.3% |
| 2022 | $20.61M | -65.2% |
| 2021 | $59.22M | +7.2% |
| 2020 | $55.24M | +1504.8% |
| 2019 | $3.44M | - |